Examination of Safety and Effectiveness of IK-3001 (Nitric Oxide for Inhalation) in Japanese Subjects With Pulmonary Hypertension Associated With Cardiac Surgery - Multi-Center, Open-Label, Clinical Study

Trial Profile

Examination of Safety and Effectiveness of IK-3001 (Nitric Oxide for Inhalation) in Japanese Subjects With Pulmonary Hypertension Associated With Cardiac Surgery - Multi-Center, Open-Label, Clinical Study

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Pulmonary hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Ikaria Holdings
  • Most Recent Events

    • 16 Apr 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
    • 17 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top